Valuation: Terumo Corporation

Market Cap 3,256B 20.04B 17.52B 16.2B 14.86B 28.13B 1,931B 28.62B 193B 75.89B 943B 75.26B 73.6B P/E 2027 *
19.5x
P/E 2028 * 17.5x
Enterprise Value 3,331B 20.51B 17.92B 16.58B 15.21B 28.79B 1,976B 29.29B 198B 77.66B 965B 77.01B 75.31B EV / Sales 2027 *
2.69x
EV / Sales 2028 * 2.49x
Free-Float
97.07%
Yield 2027 *
1.62%
Yield 2028 * 1.8%
1 day+1.26%
1 week-3.05%
Current month-1.21%
1 month-1.34%
3 months+0.91%
6 months-1.47%
Current year-2.78%
1 week 2,168.5
Extreme 2168.5
2,266.5
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-3.05%-9.62%+1.35% 19.83B
+10.72%+4.31%-25.25%-7.97% 155B
+3.81%+0.96%-7.35%-4.07% 103B
+4.13%+1.80%+3.38%+60.25% 57.7B
-1.11%+4.77%+38.09%+52.37% 52.27B
+3.02%+5.15%-11.02%-38.19% 42.68B
+3.94%+0.50% - - 33.35B
+6.74%+5.67%-8.28%-43.86% 28.06B
+0.74%+1.23%+61.36%-5.62% 25.36B
-0.85%+8.07%-4.63%-18.66% 21.03B
Average +3.20%+0.79%+4.07%-0.49% 53.88B
Weighted average by Cap. +5.00%-1.26%-3.82%+2.35%

Financials

2027 *2028 *
Net sales 1,239B 7.62B 6.66B 6.16B 5.66B 10.7B 735B 10.89B 73.5B 28.87B 359B 28.63B 28B 1,317B 8.11B 7.09B 6.55B 6.01B 11.38B 781B 11.58B 78.17B 30.71B 382B 30.45B 29.78B
Net income 166B 1.02B 892M 825M 757M 1.43B 98.32B 1.46B 9.84B 3.86B 48.01B 3.83B 3.75B 185B 1.14B 998M 923M 847M 1.6B 110B 1.63B 11.01B 4.32B 53.72B 4.29B 4.19B
Net Debt 75.69B 466M 407M 377M 346M 654M 44.89B 665M 4.49B 1.76B 21.92B 1.75B 1.71B 14.29B 87.96M 76.89M 71.11M 65.25M 123M 8.48B 126M 848M 333M 4.14B 330M 323M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
16/07/26 ¥2,207.00 +1.26% 3,874,900
15/07/26 ¥2,179.50 -2.40% 3,917,600
14/07/26 ¥2,233.00 +0.88% 3,221,300
13/07/26 ¥2,213.50 +1.12% 3,004,900
10/07/26 ¥2,189.00 -1.73% 4,601,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,207.00JPY
Average target price
2,961.54JPY
Spread / Average Target
+34.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock